CIBC World Market’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-14,050
Closed -$359K – 1230
2023
Q2
$359K Buy
+14,050
New +$333K ﹤0.01% 993
2021
Q4
– Sell
-24,484
Closed -$1.16M – 1355
2021
Q3
$1.16M Buy
+24,484
New +$1.14M ﹤0.01% 736
2020
Q1
– Sell
-8,934
Closed -$310K – 1046
2019
Q4
$310K Buy
+8,934
New +$302K ﹤0.01% 944
2019
Q2
– Sell
-29,512
Closed -$989K – 1157
2019
Q1
$989K Buy
+29,512
New +$929K ﹤0.01% 666
2018
Q4
– Sell
-105,676
Closed -$4.06M – 1123
2018
Q3
$4.06M Buy
105,676
+90,090
+578% +$3.31M 0.02% 342
2018
Q2
$547K Buy
15,586
+6,900
+79% +$241K ﹤0.01% 829
2018
Q1
$289K Buy
+8,686
New +$296K ﹤0.01% 996

Other funds holding FFTY

CIBC World Market's FFTY Position: Q3 2023 in Review

CIBC World Market sold out of CapForce IBD 50 ETF (FFTY) in Q3 2023, closing a stake of 14,050 shares — an estimated $359K sold.

CIBC World Market first reported a position in FFTY in Q1 2018 and held it in 7 quarters. The position peaked at $4.06M in Q3 2018. 40 funds tracked by Wall St. Rank hold FFTY as of Q3 2023.

  • CIBC World Market reported no remaining CapForce IBD 50 ETF position as of Q3 2023 after selling out during the quarter.
  • CIBC World Market sold 14,050 CapForce IBD 50 ETF shares in Q3 2023, an estimated $359K.
  • CIBC World Market first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 7 quarters.
  • CIBC World Market's CapForce IBD 50 ETF position peaked at $4.06M in Q3 2018.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2023.

Based on CIBC World Market's 13F filing for Q3 2023, filed 13 Nov 2023.